Flare Therapeutics raised $123 million in Series B funding to power its clinical trial to delve into its oncology program.
Health, Wellness & Biotech
Artera, which uses artificial intelligence for cancer testing and personalized care, raised a $90 million round to support the distribution of its...
Another San Francisco-based AI company came in near the top of this week's list. Investors seem to have blinders on for AI startups right now, so...
Health care and life sciences startups relied heavily on Silicon Valley Bank, and its demise may force a shift to more traditional banks.
SVB was an active pillar in the biotech community, and its downfall leaves life sciences companies particularly vulnerable.
The big news of the week in venture obviously is not who raised what but rather where will they put that money? Nevertheless, there were some big...
Given the notoriously awful performance of so many SPAC mergers, you’d think new deals wouldn’t be happening. But you would be wrong — we are still...
In February of last year, more than a dozen firms announced 10 or more deals, with several participating in 20 or more. Last month, just two...
In recent months, Series B funding to U.S. startups has fallen sharply. So far in 2023, investment is on track to come in at the lowest quarterly...
Five companies joined The Crunchbase Unicorn Board in February — the fourth month in a row for new unicorns to number in the single digits.
Startups in cyber, defense and biotech all saw some large rounds in a week that for once was not dominated by artificial intelligence.
67.1K Followers